Advertisement


Allison Kurian, MD, on Assessing Quality in the Age of Precision Medicine

2016 Quality Care Symposium

Advertisement

Allison Kurian, MD, of Stanford University School of Medicine, discusses pressing questions about the clinical utility and value of extended genomic testing and other forms of precision medicine.



Related Videos

Palliative Care
Cost of Care

Kerin B. Adelson, MD, on Improving End-of-Life Planning and Reducing Futile Care

Kerin B. Adelson, MD, of the Yale Cancer Center, discusses the major healthcare cost drivers at the end of life—aggressive treatments, emergency room visits, and futile care—and strategies for improving value. (Abstract 3)

Issues in Oncology

Randall F. Holcombe, MD, on Delivering Quality Care in a Large, Urban Institution

Randall F. Holcombe, MD, of the Icahn Mount Sinai School of Medicine, discusses the challenges of delivering quality care in an academic setting at a large hospital.

Issues in Oncology

Ethan Basch, MD, on Assessing Quality: Patient-Reported Data

Ethan Basch, MD, of the University of North Carolina at Chapel Hill, summarizes a session he chaired on the burgeoning use of patient-reported outcomes and wearable sensors in clinical practice and research.

Health-Care Policy

Robert Miller, MD: CancerLinQ Update

Robert Miller, MD, ASCO’S Vice President of Quality and Guidelines, discusses CancerLinQ, the “big data” technology platform, and implementation of a rapid learning system for oncology based on Institute of Medicine principles.

Survivorship

Lawrence N. Shulman, MD, on Survival as a Measure of Quality and Advances in Therapy

Lawrence N. Shulman, MD, of the University of Pennsylvania, discusses his paper, which explores lessons learned from analyses of the National Cancer Data Base. (Abstract 173)

Advertisement

Advertisement




Advertisement